Druggability

LW Louise V Wain
NS Nick Shrine
MA María Soler Artigas
AE A Mesut Erzurumluoglu
BN Boris Noyvert
LB Lara Bossini-Castillo
MO Ma’en Obeidat
AH Amanda P Henry
MP Michael A Portelli
RH Robert J Hall
CB Charlotte K Billington
TR Tracy L Rimington
AF Anthony G Fenech
CJ Catherine John
TB Tineka Blake
VJ Victoria E Jackson
RA Richard J Allen
BP Bram P Prins
AC Archie Campbell
DP David J Porteous
MJ Marjo-Riitta Jarvelin
MW Matthias Wielscher
AJ Alan L James
JH Jennie Hui
NW Nicholas J Wareham
JZ Jing Hua Zhao
JW James F Wilson
PJ Peter K Joshi
BS Beate Stubbe
RR Rajesh Rawal
HS Holger Schulz
MI Medea Imboden
NP Nicole M Probst-Hensch
SK Stefan Karrasch
CG Christian Gieger
ID Ian J Deary
SH Sarah E Harris
JM Jonathan Marten
IR Igor Rudan
SE Stefan Enroth
UG Ulf Gyllensten
SK Shona M Kerr
OP Ozren Polasek
MK Mika Kähönen
IS Ida Surakka
VV Veronique Vitart
CH Caroline Hayward
TL Terho Lehtimäki
OR Olli T Raitakari
DE David M Evans
request Request a Protocol
ask Ask a question
Favorite

We searched the ChEMBL database (v21, last update: 01/02/2016, downloaded on 11/02/16) to identify whether any of the implicated genes encoded proteins that were targets for approved drugs, or drug compounds in development. We additionally searched for genes predicted to interact (parameters: STRING score ≥0.90; maximum of 10 interactions per gene) with each of the high-priority genes32.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A